Truist cuts Teleflex target from USD 150 to USD 142 for Teleflex stock

Published on 10/20/2026 at 13:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue reached USD 570.33 million, up 28.9 percent year over year. Teleflex stock costs EUR 115.85 on October 20, 2026.

Target cut and earnings setup

Truist lowered its Teleflex target to USD 142 on October 14, 2026.
Second-quarter revenue grew 28.9 percent to USD 570.33 million.
Teleflex stock traded at EUR 115.85 at 1:40 p.m. CEST at Lang & Schwarz on October 20, 2026.

Makroaufnahme einer durchsichtigen Katheterspitze aus medizinischem Silikon mit Wassertropfen — Teleflex Inc. (US8793691069) illustriert durch eine Makroaufnahme einer transparenten medizinischen Katheterspitze mit Markierungen, Illustration mit AI erstellt.

Teleflex Inc. (ISIN US8793691069) had its Truist price target cut from USD 150 to USD 142 on October 14, 2026, according to Markets Insider. The stock was trading at EUR 115.85 at Lang & Schwarz on October 20, 2026 at 1:40 p.m. CEST, keeping the analyst reset ahead of the companys next results.

Target cut sharpens the test

The Truist move leaves a USD 142 target against the analysts earlier USD 150 level. Markets Insider reported that analyst Richard Newitter maintained a Hold rating while citing a mixed third-quarter setup and pressure on future estimates.

What does the guidance mean for margins?

Teleflex reported second-quarter 2026 revenue of USD 570.33 million, up 28.9 percent from the prior year, while adjusted earnings per share reached USD 1.76. The companys 2026 pro forma adjusted constant-currency revenue growth guidance was reduced to 3.5 percent to 4.5 percent from 4.5 percent to 5.5 percent, while adjusted earnings per share guidance rose to USD 6.90 to USD 7.20 from USD 6.25 to USD 6.55, according to Benzinga. The tension is clear: interventional integration is weighing on growth, while cost actions and lower interest expense support earnings.

Three milestones shape the story

On August 6, 2026, Teleflex reported USD 570.33 million in second-quarter revenue and adjusted earnings per share of USD 1.76 through the earnings call transcript published by Benzinga. On October 12, 2026, Teleflex announced enrollment of 102 patients across 14 European centers in the BIOMAG-LL study, according to Teleflex. On October 14, 2026, Truist lowered its target from USD 150 to USD 142 while retaining Hold, as reported by Markets Insider.

Next dates for Teleflex

Yahoo Finance lists October 29, 2026 as the next earnings date. That report should provide the next direct check on the 3.5 percent to 4.5 percent full-year revenue growth outlook and the integration timetable.

Stock stays below the annual high

Teleflex is listed on the NYSE under ticker TFX and operates in medical devices. Its USD 5.5 billion market capitalization and USD 100.18 to USD 145.00 52-week range frame the valuation question, while the October 14 target cut puts execution at the center of the debate.

The stock was trading at EUR 115.85 at Lang & Schwarz on October 20, 2026 at 1:40 p.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of Teleflex stock.